Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections.

By D. Agnese, Jacqueline E. Calvano, Sae J. Hahm, S. Coyle, S. Corbett, S. Calvano, S. Lowry. Journal of Infectious Diseases, 2002

610 citations recorded by the source corpus.

Subfields: Epidemiology, Immunology

View Paper: https://www.semanticscholar.org/paper/fb188a924e7c6f048612c19b0c6d89231a1243de

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. L. Zitvogel
2. Oliver Kepp
3. A. Tesnière

In Immunology

1. L. Zitvogel
2. Oliver Kepp
3. Robert Bals
4. François Ghiringhelli
5. A. Tesnière
6. P. Hiemstra
7. Guido Kroemer
8. L. Galluzzi

Citations in the corpus

• Immunogenic death of colon cancer cells treated with oxaliplatin (2010, background): “5%) as in the general Caucasian population (12–14%) (Arbour et al., 2000; Agnese et al., 2002).”
• Innate immunity in the lung: how epithelial cells fight against respiratory pathogens (2004, background): “Subsequent studies in humans revealed an association of selected polymorphisms in the human TLR4 gene with a variety of diseases, including Gram-negative bacterial infections in patients in an intensive care unit [ 12 ].”